Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

TTK HEALTHCARE 2023-24 Annual Report Analysis
Tue, 2 Jul

TTK HEALTHCARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

TTK HEALTHCARE Income Statement Analysis

  • Operating income during the year rose 3.8% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 19.1% YoY during the fiscal. Operating profit margins witnessed a fall and down at 5.0% in FY24 as against 4.3% in FY23.
  • Depreciation charges increased by 2.0% and finance costs decreased by 47.4% YoY, respectively.
  • Other income grew by 29.5% YoY.
  • Net profit for the year grew by 40.7% YoY.
  • Net profit margins during the year grew from 6.2% in FY23 to 8.3% in FY24.

TTK HEALTHCARE Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 7,251 7,528 3.8%
Other income Rs m 483 626 29.5%
Total Revenues Rs m 7,734 8,154 5.4%
Gross profit Rs m 313 373 19.1%
Depreciation Rs m 128 131 2.0%
Interest Rs m 52 28 -47.4%
Profit before tax Rs m 616 841 36.5%
Tax Rs m 170 213 25.4%
Profit after tax Rs m 447 628 40.7%
Gross profit margin % 4.3 5.0
Effective tax rate % 27.5 25.3
Net profit margin % 6.2 8.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Key Information for Long-term Investors

TTK HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY24 down at Rs 2 billion as compared to Rs 2 billion in FY23, thereby witnessing an decrease of -7.1%.
  • Current assets rose 1% and stood at Rs 11 billion, while fixed assets rose 18% and stood at Rs 1 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 12 billion as against Rs 12 billion during FY23, thereby witnessing a growth of 3%.

TTK HEALTHCARE Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 9,534 10,009 5.0
 
Current Liabilities Rs m 2,108 1,958 -7.1
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 11,658 11,952 2.5
 
Current assets Rs m 10,661 10,773 1.1
Fixed Assets Rs m 997 1,179 18.2
Total Assets Rs m 11,658 11,952 2.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



TTK HEALTHCARE Cash Flow Statement Analysis

  • TTK HEALTHCARE's cash flow from operating activities (CFO) during FY24 stood at Rs -49 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs 285 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -219 million on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs 16 million from the Rs -55 million net cash flows seen during FY23.

TTK HEALTHCARE Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m -248 -49 -
Cash Flow from Investing Activities Rs m 317 285 -10.1%
Cash Flow from Financing Activities Rs m -124 -219 -
Net Cash Flow Rs m -55 16 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for TTK HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 44.5, an improvement from the EPS of Rs 31.6 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,460.0, stands at 32.8 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.1 times, while the price to sales ratio stands at 2.7 times.
  • The company's price to cash flow (P/CF) ratio stood at 25.4 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 513.2 532.8
TTM Earnings per share Rs 31.6 44.5
Diluted earnings per share Rs 31.6 44.5
Price to Cash Flow x 25.4 25.4
TTM P/E ratio x 32.7 32.8
Price / Book Value ratio x 1.3 1.9
Market Cap Rs m 12,529 19,251
Dividends per share (Unadj.) Rs 10.0 10.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for TTK HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 5.5x during FY24, from 5.1x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 31.5x during FY24, from 12.8x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 6.3% during FY24, from 4.7% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 8.7% during FY24, from 7.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 5.5% during FY24, from 4.3% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 5.1 5.5
Debtors’ Days Days 464 419
Interest coverage x 12.8 31.5
Debt to equity ratio x 0.0 0.0
Return on assets % 4.3 5.5
Return on equity % 4.7 6.3
Return on capital employed % 7.0 8.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how TTK HEALTHCARE has performed over the last 5 years, please visit here.

TTK HEALTHCARE Share Price Performance

Over the last one year, TTK HEALTHCARE share price has moved up from Rs 1,246.7 to Rs 1,460.0, registering a gain of Rs 213.4 or around 17.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 37,217.4 (down 0.1%). Over the last one year it has moved up from 25,814.5 to 37,217.4, a gain of 11,403 points (up 44.2%).

Overall, the S&P BSE SENSEX is up 24.4% over the year.

(To know more, check out historical annual results for TTK HEALTHCARE and quarterly results for TTK HEALTHCARE)

Annual Report FAQs

What is the current share price of TTK HEALTHCARE?

TTK HEALTHCARE currently trades at Rs 1,445.4 per share. You can check out the latest share price performance of TTK HEALTHCARE here...

What was the revenue of TTK HEALTHCARE in FY24? How does it compare to earlier years?

The revenues of TTK HEALTHCARE stood at Rs 8,154 m in FY24, which was up 5.4% compared to Rs 7,734 m reported in FY23.

TTK HEALTHCARE's revenue has grown from Rs 6,545 m in FY20 to Rs 8,154 m in FY24.

Over the past 5 years, the revenue of TTK HEALTHCARE has grown at a CAGR of 5.6%.

What was the net profit of TTK HEALTHCARE in FY24? How does it compare to earlier years?

The net profit of TTK HEALTHCARE stood at Rs 628 m in FY24, which was up 40.7% compared to Rs 447 m reported in FY23.

This compares to a net profit of Rs 185 m in FY22 and a net profit of Rs 368 m in FY21.

Over the past 5 years, TTK HEALTHCARE net profit has grown at a CAGR of 50.3%.

What does the cash flow statement of TTK HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of TTK HEALTHCARE reveals:

  • Cash flow from operations increased in FY24 and stood at Rs -49 m as compared to Rs -248 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs 285 m as compared to Rs 317 m in FY23.
  • Cash flow from financial activity decreased in FY24 and stood at Rs -219 m as compared to Rs -124 m in FY23.

Here's the cash flow statement of TTK HEALTHCARE for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations198964450-248-49
From Investments-133-772-296317285
From Financial Activity-102-172-101-124-219
Net Cashflow-362053-5516

What does the Key Ratio analysis of TTK HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of TTK HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and down at 5.0% in FY24 as against 4.3% in FY23.
  • Net profit margins grew from 6.2% in FY23 to 8.3% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of TTK HEALTHCARE for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)4.45.84.14.35.0
Net Profit Margin (%)1.97.73.16.28.3
Debt to Equity Ratio (x)0.00.00.00.00.0

 

Equitymaster requests your view! Post a comment on "TTK HEALTHCARE 2023-24 Annual Report Analysis". Click here!